These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3674183)

  • 21. Topical fibronectin in an alkali burn model of corneal ulceration in rabbits.
    Phan TM; Foster CS; Shaw CD; Zagachin LM; Colvin RB
    Arch Ophthalmol; 1991 Mar; 109(3):414-9. PubMed ID: 2003805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of transforming growth factor-beta 2, interleukin 6 and fibronectin on corneal epithelial wound healing.
    Er H; Uzmez E
    Eur J Ophthalmol; 1998; 8(4):224-9. PubMed ID: 9891893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical fibronectin and aprotinin for keratectomy wound healing in rabbits.
    Boisjoly HM; Sun R; Giasson M; Beaulieu A
    Arch Ophthalmol; 1990 Dec; 108(12):1758-63. PubMed ID: 1701629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions.
    Nishida T; Inui M; Nomizu M
    Prog Retin Eye Res; 2015 Jul; 47():38-63. PubMed ID: 25645519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers.
    Aifa A; Gueudry J; Portmann A; Delcampe A; Muraine M
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8181-5. PubMed ID: 23150626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amniotic membrane transplantation for persistent epithelial defects with ulceration.
    Lee SH; Tseng SC
    Am J Ophthalmol; 1997 Mar; 123(3):303-12. PubMed ID: 9063239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of the Corneal Stroma Associated With Rapid Reepithelialization Induced by the Fibronectin-Derived Peptide PHSRN in 2 Cases of Corneal Perforation Due to a Persistent Epithelial Defect.
    Morita Y; Morishige N; Yamada N; Ohta M; Sonoda KH; Nishida T
    Cornea; 2015 Nov; 34(11):1504-7. PubMed ID: 26312620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cultural study on corneal explants and clinic assessment of the effectiveness of treating corneal ulcers induced by alkal test with topic aprotinin and fibronectin.
    Cosimi MF; Cerqueti MP; Lomolino G; Re P; Casagranda I
    Pathologica; 1994 Feb; 86(1):74-6. PubMed ID: 7521030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and histological findings on the effect of fibronectin in rabbits with experimental corneal disorders.
    Hiraki S; Hayami H; Numata K; Kubota Y; Kobayashi M; Tanaka S; Karges HE
    Arzneimittelforschung; 1990 Dec; 40(12):1336-40. PubMed ID: 1710125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical insulin for refractory persistent corneal epithelial defects.
    Abdi P; Ghaffari R; Azad N; Alshaheeb A; Latifi G; Soltani Shahgoli S; Fakhredin H
    Sci Rep; 2024 May; 14(1):12459. PubMed ID: 38816428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens.
    Rosenthal P; Cotter JM; Baum J
    Am J Ophthalmol; 2000 Jul; 130(1):33-41. PubMed ID: 11004257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits.
    Akyol-Salman I
    Cornea; 2006 Dec; 25(10):1178-81. PubMed ID: 17172894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term restoration of corneal sensitivity in neurotrophic keratopathy after rhNGF treatment.
    Di Zazzo A; Varacalli G; Mori T; Coassin M
    Eur J Ophthalmol; 2022 Jan; 32(1):NP15-NP18. PubMed ID: 32854535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibitors of plasmin-like enzymes and autofibronectin in the treatment of corneal epithelial defects].
    Polunin GS; Kasparov AA; Makarov IA; Ovchinnikov AN
    Vestn Oftalmol; 1993; 109(4):14-6. PubMed ID: 7506465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of treatment of mooren ulcer with topical cyclosporine a 2%.
    Tandon R; Chawla B; Verma K; Sharma N; Titiyal JS
    Cornea; 2008 Sep; 27(8):859-61. PubMed ID: 18724142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pathogenesis of corneal epithelial defects.
    Berman M
    Acta Ophthalmol Suppl (1985); 1989; 192():55-64. PubMed ID: 2554658
    [No Abstract]   [Full Text] [Related]  

  • 38. Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis.
    Cameron JA
    Ophthalmology; 1995 Jun; 102(6):985-93. PubMed ID: 7777308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The efficiency of treating ulcerative corneal lesions with fibro nectin].
    Adamova NA; Gorgiladze TU; Artemov AV
    Oftalmol Zh; 1990; (4):245-8. PubMed ID: 2255507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the Effect of Autologous Serum on Therapy Resistant Corneal Erosions and Ulcers on the Corneal Graft vs. the Patient's Own Cornea].
    Leonhard M; Turner C; Langenbucher A; Flockerzi E; Seitz B
    Klin Monbl Augenheilkd; 2024 Jan; 241(1):102-109. PubMed ID: 37164338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.